Most Popular

RBC Capital Maintains Outperform On Avago Technologies Ltd (AVGO) After Meeting With Management

In a research report released today, RBC Capital analyst Amit Daryanani maintained an Outperform rating on shares of Avago Technologies Ltd (NASDAQ:AVGO) with a price target of $150, following …

Opko Health Inc. Coverage Assumed with Hold at Jefferies; Here’s Why

Jefferies analyst Brandon Couillard came out with a research report on Opko Health Inc. (NYSE:OPK) Friday, assuming coverage with a Hold rating and raising the price target to …

Oppenheimer Weighs in On Geron Corporation (GERN) Following ET and MF Study Publications

In a research report issued today, Oppenheimer’s healthcare analyst Ling Wang reiterated an Outperform rating on shares of Geron Corporation (NASDAQ:GERN) with a $5.50 …

Paypal Holdings Inc (PYPL) Offers Limited Downside and Attractive Risk-Reward: Deutsche Bank

Deutsche Bank analyst Bryan Keane came out with a favorable report on Paypal Holdings Inc (NASDAQ:PYPL), reiterating a Buy rating, with a price target …

Analysts Remain Bullish on Sangamo Biosciences, Inc. (SGMO) Following Restructuring Collaboration Announcement

Yesterday, Sangamo Biosciences, Inc. (NASDAQ:SGMO) announced it will be restructuring its collaboration with Shire PLC (ADR) (NASDAQ:SHPG) in order to speed up the …

Twitter Inc On The Right Track To Grow MAU From Deal With Google Inc: Canaccord Weighs In

Social media giant Twitter Inc (NASDAQ:TWTR) confirmed a deal with Google Inc (NASDAQ:GOOGL) back in May in enables real-time tweets to appear in …

Deutsche Bank Offers Commentary On Freeport-McMoRan Inc In Light Of Mining Costs Cut

In a research report released Friday, Deutsche Bank analyst Jorge Beristain reiterated a Buy rating on shares of Freeport-McMoRan Inc (NYSE:FCX) with a $17 price …

Piper Jaffray Weighs In on Amgen, Inc. (AMGNׁ) Following Repatha FDA Approval

Piper Jaffray’s healthcare analyst Joshua Schimmer weighed in with his views on Amgen, Inc. (NASDAQ:AMGN), following the news that the company received FDA approval for its PCSK9 inhibitor …

Equity Market Recovering Like October 2014

On Tuesday I wrote about the bulls waiting for that elusive equity market bounce. The wait was short as the market snap back …

Will The Fallout From China Favour Equities, Bonds or the US Dollar?

It had been a typical summer market until the past fortnight. Major markets had been range bound, pending the widely-anticipated rate increase from …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts